Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Giovannoni

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
European Journal of Medicinal Chemistry|July 12, 2000
Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologiesV Dal Piaz, M P Giovannoni
Drug Design and Discovery|March 1, 1996
Synthesis and evaluation as platelet aggregation inhibitors of 6-phenyl-2,4-substituted-3(2H)-pyridazinones and their rigid analogues benzo[h]cinnolin-3,5-dionesV Dal Piaz, G Ciciani, M P Giovannoni
Farmaco (Societa Chimica Italiana : 1989)|July 1, 1991
Synthesis and evaluation of in vitro antitumor activity of some substituted 5-pyridazinyl-styrylketonesG Ciciani, V Dal Piaz, M P Giovannoni
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1997
Synthesis of 4,5-functionalized-2-methyl-6-(substituted aryl)-3 (2H)-pyridazinones: a new group of potent platelet aggregation inhibitorsV Dal Piaz, G Ciciani, M P Giovannoni
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1991
New 6-cyano-3-phenyl-1-,2,3,4-tetrahydro-1,2-diazepin-5-ones: synthesis and in vitro antitumor activity evaluationV Dal Piaz, G Ciciani, M P Giovannoni
Current Medicinal Chemistry|May 25, 2010
PDE5 inhibitors and their applicationsM P Giovannoni, C Vergelli, A Graziano, et al.
Mini Reviews in Medicinal Chemistry|July 23, 2003
Selective ACAT inhibitors as promising antihyperlipidemic, antiathero-sclerotic and anti-Alzheimer drugsM P Giovannoni, V Dal Piaz, C Vergelli, et al.
Expert Opinion on Therapeutic Patents|June 18, 2019
A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applicationsL Crocetti, M T Quinn, I A Schepetkin, et al.
Chirality|January 1, 1997
Chiral resolution and absolute configuration of the enantiomers of 5-acetyl-2-methyl-4-methylsulfinyl-6-phenyl-3(2H)-pyridazinone and evaluation of their platelet aggregation inhibitory activityO Azzolina, V Dal Piaz, S Collina, et al.
Pharmacological Research|May 1, 1994
4-substituted-5-acetyl-2-methyl-6-phenyl-3(2H)pyridazinones as PGE2 and IL-1 release inhibitors from mouse adherent macrophagesV Dal Piaz, M P Giovannoni, G Ciciani, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Medicinal Chemistry|July 12, 2000
Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologiesV Dal Piaz, M P Giovannoni
Drug Design and Discovery|March 1, 1996
Synthesis and evaluation as platelet aggregation inhibitors of 6-phenyl-2,4-substituted-3(2H)-pyridazinones and their rigid analogues benzo[h]cinnolin-3,5-dionesV Dal Piaz, G Ciciani, M P Giovannoni
Farmaco (Societa Chimica Italiana : 1989)|July 1, 1991
Synthesis and evaluation of in vitro antitumor activity of some substituted 5-pyridazinyl-styrylketonesG Ciciani, V Dal Piaz, M P Giovannoni
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1997
Synthesis of 4,5-functionalized-2-methyl-6-(substituted aryl)-3 (2H)-pyridazinones: a new group of potent platelet aggregation inhibitorsV Dal Piaz, G Ciciani, M P Giovannoni
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1991
New 6-cyano-3-phenyl-1-,2,3,4-tetrahydro-1,2-diazepin-5-ones: synthesis and in vitro antitumor activity evaluationV Dal Piaz, G Ciciani, M P Giovannoni
Current Medicinal Chemistry|May 25, 2010
PDE5 inhibitors and their applicationsM P Giovannoni, C Vergelli, A Graziano, et al.
Mini Reviews in Medicinal Chemistry|July 23, 2003
Selective ACAT inhibitors as promising antihyperlipidemic, antiathero-sclerotic and anti-Alzheimer drugsM P Giovannoni, V Dal Piaz, C Vergelli, et al.
Expert Opinion on Therapeutic Patents|June 18, 2019
A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applicationsL Crocetti, M T Quinn, I A Schepetkin, et al.
Chirality|January 1, 1997
Chiral resolution and absolute configuration of the enantiomers of 5-acetyl-2-methyl-4-methylsulfinyl-6-phenyl-3(2H)-pyridazinone and evaluation of their platelet aggregation inhibitory activityO Azzolina, V Dal Piaz, S Collina, et al.
Pharmacological Research|May 1, 1994
4-substituted-5-acetyl-2-methyl-6-phenyl-3(2H)pyridazinones as PGE2 and IL-1 release inhibitors from mouse adherent macrophagesV Dal Piaz, M P Giovannoni, G Ciciani, et al.
Pageof 3